Tune Therapeutics unveils potentially curative approach to treating chronic HBV infection

Pioneering epigenome editing company Tune Therapeutics has announced it is working on a new and potentially curative approach to treating chronic HBV infection.

Odesza at Folsom Field ushers in a new concert era for CU Boulder – The Cannabist

If anyone in Boulder hears a rumbling sound emanating from the University of Colorado Boulder campus this weekend, fear not. No volcano is brewing. It’s

June 28, 2024

A broad new idea for treating viral infections: blowing up their protective membranes

Chemists are zeroing in on a new antiviral strategy that they hope could be deployed against a wide variety of pathogens. The experimental drugs blow

August 3, 2023

Antisense RNA acts as a cellular ‘booster’ for gene expression, study finds

The function of non-coding RNA in the cell has long been a mystery to researchers. Unlike coding RNA, non-coding RNA does not produce proteins –

June 24, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.